News French drug trial had three major failings, says initial report BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i784 (Published 08 February 2016) Cite this as: BMJ 2016;352:i784 Article Related content Metrics Responses Peer review Related articles News Details of French trial must be released urgently, say UK experts Published: 18 January 2016; BMJ 352 doi:10.1136/bmj.i319 Editorial Lessons from the fatal French study BIA-10-2474 Published: 18 May 2016; BMJ 353 doi:10.1136/bmj.i2727 News French drug agency was not wrong to allow deadly trial, review says Published: 23 May 2016; BMJ 353 doi:10.1136/bmj.i2774 See more Prostate cancer: Could polygenic risk scores make national screening a reality? BMJ April 15, 2025, 389 r763; DOI: https://doi.org/10.1136/bmj.r763 NICE recommends “targeted” drug capivasertib for advanced breast cancer BMJ April 14, 2025, 389 r762; DOI: https://doi.org/10.1136/bmj.r762 Cancer: People in UK’s poorest areas have longer waits for care and higher death rates BMJ February 21, 2025, 388 r367; DOI: https://doi.org/10.1136/bmj.r367 Hospitals are urged to learn from case of delayed cancer diagnosis after failure to follow up BMJ February 06, 2025, 388 r264; DOI: https://doi.org/10.1136/bmj.r264 Calcium rich diet could reduce bowel cancer risk, study finds BMJ January 08, 2025, 388 r42; DOI: https://doi.org/10.1136/bmj.r42 Cited by... French drug agency was not wrong to allow deadly trial, review saysFulltext PDF Lessons from the fatal French study BIA-10-2474Fulltext PDF
